Search Results - Jhuti, Gurleen Singh

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Abstract P6-13-01: Cost-effectiveness of ado-trastuzumab emtansine (T-DM1) versus trastuzumab (H) for the adjuvant treatment of patients with residual invasive HER2+ early breast cancer in the US

    Abstract P6-13-01: Cost-effectiveness of ado-trastuzumab emtansine (T-DM1) versus trastuzumab (H) for the adjuvant treatment of patients with residual invasive HER2+ early breast c... by Goertz, Hans-Peter, Herrera-Restrepo, Oscar, Wehler, Elizabeth, Bilir, Pinar, Antao, Vincent, Jhuti, Gurleen Singh

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Population-level impact of adjuvant trastuzumab emtansine on the incidence of metastatic breast cancer: an epidemiological prediction model of women with HER2-positive early breast cancer and residual disease following neoadjuvant therapy

    Population-level impact of adjuvant trastuzumab emtansine on the incidence of metastatic breast cancer: an epidemiological prediction model of women with HER2-positive early breast... by Williamson, Mellissa, Press, David J., Hansen, Svenn Alexander, Tomar, Akanksha, Jhuti, Gurleen Singh, Revil, Cedric, Gururaj, Kaustubh

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:

Search Tools: